相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuromyelitis Optica Spectrum Disorder Treatment-Current and Future Prospects
Marta Waliszewska-Prosol et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Interleukin-22 Influences the Th1/Th17 Axis
Hannes Lindahl et al.
FRONTIERS IN IMMUNOLOGY (2021)
Lower serum interleukin-22 and interleukin-35 levels are associated with disease status in neuromyelitis optica spectrum disorders
Hong Yang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Race and ethnicity on MS presentation and disease course
Lilyana Amezcua et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Martina Kunkl et al.
CELLS (2020)
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients
Jan Traub et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Interleukin-17 in Chronic Inflammatory Neurological Diseases
Jelena Milovanovic et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
Mario Stampanoni Bassi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
Agnieshka M. Agasing et al.
NATURE COMMUNICATIONS (2020)
Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway
Li Du et al.
LIFE SCIENCES (2020)
Genetic factors for susceptibility to and manifestations of neuromyelitis optica
Takuya Matsushita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
Kazuo Fujihara et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only
S. Kalra et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2020)
Markedly Elevated Serum Level of T-Helper Cell 17-Related Cytokines/Chemokines in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis
Hao Kang et al.
FRONTIERS IN NEUROLOGY (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Neuromyelitis optica spectrum disorders
Saif Huda et al.
CLINICAL MEDICINE (2019)
Multiple Sclerosis Misdiagnosis: A Persistent Problem to Solve
Maria I. Gaitan et al.
FRONTIERS IN NEUROLOGY (2019)
Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients
Lukasz Rzepinski et al.
MEDICINA-LITHUANIA (2019)
IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients
Yuling Shi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Environmental and genetic risk factors for MS: an integrated review
Emmanuelle Waubant et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis
Miao-Miao Hou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study
Andrei Miclea et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Misdiagnosis of multiple sclerosis Impact of the 2017 McDonald criteria on clinical practice
Andrew J. Solomon et al.
NEUROLOGY (2019)
Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study
Sharareh Eskandarieh et al.
ACTA NEUROLOGICA BELGICA (2018)
Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets
Peng-Peng Ip et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Severe course of neuromyelitis optica in a female patient with chronic C hepatitis
Krystian Obara et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2018)
The Properties of Cytokines in Multiple Sclerosis: Pros and Cons
Kexin Wang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow et al.
FRONTIERS IN NEUROLOGY (2018)
IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria
K. L. Flannigan et al.
MUCOSAL IMMUNOLOGY (2017)
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Nadja Borisow et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Nadja Borisow et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
Taku Kuwabara et al.
MEDIATORS OF INFLAMMATION (2017)
Microglial Interferon Signaling and White Matter
Ashley McDonough et al.
NEUROCHEMICAL RESEARCH (2017)
Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
Gabriel Arellano et al.
FRONTIERS IN IMMUNOLOGY (2017)
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
Timur Khaibullin et al.
FRONTIERS IN IMMUNOLOGY (2017)
The age at onset in Multiple Sclerosis is associated with patient's prognosis
D. Cierny et al.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica
Akiyuki Uzawa et al.
CLINICA CHIMICA ACTA (2017)
Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase
P. O. Barros et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic
Remi A. Kessler et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
Th17 cells in neuromyelitis optica spectrum disorder: a review
Jie Lin et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2016)
Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic Differentiation
Hristina Obradovic et al.
MEDIATORS OF INFLAMMATION (2016)
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications
Giordani Rodrigues Dos Passos et al.
MEDIATORS OF INFLAMMATION (2016)
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder
Fumihito Yoshii et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
Nicolas Collongues et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis
Hengri Cong et al.
PLOS ONE (2016)
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives
Michalina Jasiak-Zatonska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
Jacek Tabarkiewicz et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2015)
Therapeutic Management of Severe Relapses in Multiple Sclerosis
Carolyn Bevan et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2015)
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels
Zohreh Babaloo et al.
IMMUNOLOGY LETTERS (2015)
G-CSF and GM-CSF in Neutropenia
Hrishikesh M. Mehta et al.
JOURNAL OF IMMUNOLOGY (2015)
Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Kevin S. Carbajal et al.
JOURNAL OF IMMUNOLOGY (2015)
Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review
Wildea Lice de Carvalho Jennings Pereira et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Demographic and clinical features of neuromyelitis optica: A review
L. Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
MRI characteristics of neuromyelitis optica spectrum disorder An international update
Ho Jin Kim et al.
NEUROLOGY (2015)
Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells
Chi-Keung Wan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
EPIDEMIOLOGY AND CURRENT TREATMENT OF NEUROMYELITIS OPTICA: A SYSTEMATIC REVIEW
N. Likhar et al.
VALUE IN HEALTH (2015)
Demographic and clinical features of neuromyelitis optica: A review
L. Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Update on biomarkers in neuromyelitis optica
Esther Melamed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica
Yoshinobu Kariya et al.
BBA CLINICAL (2015)
Cytokines and Chemokines in Neuromyelitis Optica: Pathogenetic and Therapeutic Implications
Akiyuki Uzawa et al.
BRAIN PATHOLOGY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Poor Responses to Interferon-Beta Treatment in Patients with Neuromyelitis Optica and Multiple Sclerosis with Long Spinal Cord Lesions
Kai-Chen Wang et al.
PLOS ONE (2014)
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO
Jeffrey M. Gelfand et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Immunology of neuromyelitis optica: a T cell-B cell collaboration
Meike Mitsdoerffer et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - A pilot study
B. D. Michael et al.
CYTOKINE (2013)
The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients
Ulisses C. Linhares et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Distinct Serum Cytokine Profiles in Neuromyelitis Optica and Multiple Sclerosis
Kai Chen Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
IL-22 secreting CD4+T cells in the patients with neuromyelitis optica and multiple sclerosis
Wen Xu et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica
Yuko Shimizu et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status
Satoshi Yoshimura et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis
Honghao Wang et al.
NEUROIMMUNOMODULATION (2013)
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
Takuya Matsushita et al.
PLOS ONE (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Ingo Kleiter et al.
ARCHIVES OF NEUROLOGY (2012)
Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
Aimin Wu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Enhanced HMGB1 Expression May Contribute to Th17 Cells Activation in Rheumatoid Arthritis
Yan Shi et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Mechanisms regulating regional localization of inflammation during CNS autoimmunity
Emily Pierson et al.
IMMUNOLOGICAL REVIEWS (2012)
Interleukin-6, a Major Cytokine in the Central Nervous System
Maria Erta et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
被撤回的出版物: Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies (Retracted article. See vol. 17, 2016)
Amedeo Amedei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence
Anu Jacob et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Su-Hyun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Th17 Response and Inflammatory Autoimmune Diseases
Janelle C. Waite et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2012)
IL-17A stimulates granulocyte colony-stimulating factor production via ERK1/2 but not p38 or JNK in human renal proximal tubular epithelial cells
Yuki Hirai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Association of Th1/Th2-Related Chemokine Receptors in Peripheral T Cells with Disease Activity in Patients with Multiple Sclerosis and Neuromyelitis Optica
Yuko Shimizu et al.
EUROPEAN NEUROLOGY (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis
Ying Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Fate mapping of IL-17-producing T cells in inflammatory responses
Keiji Hirota et al.
NATURE IMMUNOLOGY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Role of Osteopontin in Synovial Th17 Differentiation in Rheumatoid Arthritis
Guangjie Chen et al.
ARTHRITIS AND RHEUMATISM (2010)
Evidence for a cross-talk between human neutrophils and Th17 cells
Martin Pelletier et al.
BLOOD (2010)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
Stewart Leung et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Unregulated IL-23/IL-17 immune response in autoimmune diseases
Vinicius Silva Costa et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Verena Brucklacher-Waldert et al.
BRAIN (2009)
Interferon-beta(1b) Treatment in Neuromyelitis Optica
Masami Tanaka et al.
EUROPEAN NEUROLOGY (2009)
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY (2009)
IL-17 and Th17 cells in human inflammatory diseases
Pierre Miossec
MICROBES AND INFECTION (2009)
Neuromyelitis optica: Diagnosis, pathogenesis, and treatment
Bruce Cree
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2008)
Th17 cytokines and their emerging roles in inflammation and autoimmunity
Lynette A. Fouser et al.
IMMUNOLOGICAL REVIEWS (2008)
Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner
Lai Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Osteopontin - A multifunctional molecule regulating chronic inflammation and vascular disease
Marta Scatena et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
C. Papeix et al.
MULTIPLE SCLEROSIS (2007)
A secondary progressive clinical course is uncommon in neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2007)
Diagnosis and treatment of neuromyelitis optica
Dean M. Wingerchuk
NEUROLOGIST (2007)
Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis
Dean M. Wingerchuk et al.
CURRENT OPINION IN NEUROLOGY (2007)
5-aminoimidazole-4-carboxamide-1-beta4-ribofurano side attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction
Ratna Prasad et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Yutaka Komiyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
T Ishizu et al.
BRAIN (2005)
Macrophages and neurodegeneration
JJA Hendriks et al.
BRAIN RESEARCH REVIEWS (2005)
G-CSF: A key regulator of neutrophil production, but that's not all!
AW Roberts
GROWTH FACTORS (2005)
Plasma osteopontin levels in multiple sclerosis
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Regulatory roles of IL-17 and IL-17F in G-CSF production by lung microvascular endothelial cells stimulated with IL-1β and/or TNF-α
M Numasaki et al.
IMMUNOLOGY LETTERS (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients
D Goldsmith et al.
CLINICAL SCIENCE (2004)
Expression of aquaporin water channels in mouse spinal cord
K Oshio et al.
NEUROSCIENCE (2004)
Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells
AL Wurster et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line - Pathways that are shared with and distinct from IL-10
D Lejeune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β:: Critical role of STAT-1α
ZD Ma et al.
JOURNAL OF IMMUNOLOGY (2001)
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
DT Denhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
